Wall Street Zen Upgrades Braiin (NASDAQ:BRAI) to Hold

Braiin (NASDAQ:BRAI - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings initiated coverage on shares of Braiin in a research note on Wednesday. They issued a "sell (e+)" rating on the stock. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of "Sell".

Braiin Trading Down 2.3%

Shares of Braiin stock opened at $7.28 on Friday. The stock has a 50-day moving average price of $7.42. Braiin has a 1 year low of $4.19 and a 1 year high of $33.00.

Braiin News Summary

Here are the key news stories impacting Braiin this week:

• Neutral Sentiment: New MRI and brain-imaging studies suggest improved ways to identify brain biomarkers, map brain connections, and classify conditions such as migraine and Parkinson’s disease. These advances could support broader interest in brain-health technologies, but they do not directly mention Braiin or its products. Brain imaging reveals migraine headache subtypes
• Neutral Sentiment: Several reports highlight emerging research on psilocybin, GLP-1 drugs, omega-3s, supplements, and other brain-health topics, which may reinforce investor interest in the broader mental-health and neuroscience space, but the articles are not tied to Braiin’s operations. One Dose of Psilocybin Changes the Human Brain
• Neutral Sentiment: Other studies discuss brain aging, decision-making, pregnancy-related brain changes, and links between body fat and brain atrophy. These are scientifically relevant but unlikely to move BRAI shares unless Braiin is directly exposed to diagnostics, therapeutics, or brain-health products. Low Presence Of Abdominal Fat In Midlife Linked To Slower Brain Ageing: Study

Braiin Company Profile

Braiin Limited is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (“AI/ML”) technologies to deliver actionable insights across high-growth verticals: Agriculture, Property Technology, and Customer Experience as a Service (“CXaaS”). Our platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. Our first commercial focus is on the agriculture technology sector, where we have successfully deployed our AI-powered solutions across multiple implementations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.